RE:RE:Look At The Facts They Speak VolumesDavidRosenberg wrote: Walter333 wrote: Look at the facts, past performance history, and all filings over the years.
show me a biotech company with no debt on the balance sheet and with 40,000,000 USD in the bank that has 3 molecules pending the start of clinical trials that have strong IP and that nobody else has
you can't find much
FSD is undervalued in my opinion that's why i averaged down last time
all stocks carrry risks and im not a professional so dont take my word as advvice to buy sell or hold any security ever!
but for me personally i think FSD has merit if they can prove their drugs work.
Do your own DD dont listen to the bashers or pumpers on this board !!
INCYTE - 1.6 billion cash 3x current liabilities REGENERON - 7.9 billion current assets if which 3.1 is cash 2x current liabilities VERTEX - no debt 5.5 billion cash 3x current liabilities. Get off of the soap box and sit down junior. 40 mil in grifted funds from previous failed endeavours is peanuts, chump change. FSD is a minnow in the ocean.